Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.
Hiroyuki ItoSuzuko MatsumotoTakuma IzutsuEiji KusanoJiro KondoHideyuki InoueShinichi AntokuTomoko YamasakiToshiko MoriMichiko ToganePublished in: PloS one (2021)
Luseogliflozin can preserve the renal function in the medium term in patients with type 2 diabetes and renal impairment without an increase in specific adverse events.